{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:59:40Z","timestamp":1770483580828,"version":"3.49.0"},"reference-count":26,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":581,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Diabetes"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1111\/pedi.12116","type":"journal-article","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T06:58:17Z","timestamp":1390892297000},"page":"27-33","source":"Crossref","is-referenced-by-count":37,"title":["Insulin degludec's ultra-long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes"],"prefix":"10.1155","volume":"15","author":[{"given":"Torben","family":"Biester","sequence":"first","affiliation":[{"name":"Diabetes Centre for Children and Adolescents; Kinder- und Jugendkrankenhaus auf der Bult; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Blaesig","sequence":"additional","affiliation":[{"name":"Diabetes Centre for Children and Adolescents; Kinder- und Jugendkrankenhaus auf der Bult; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Remus","sequence":"additional","affiliation":[{"name":"Diabetes Centre for Children and Adolescents; Kinder- und Jugendkrankenhaus auf der Bult; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e4rbel","family":"Aschemeier","sequence":"additional","affiliation":[{"name":"Diabetes Centre for Children and Adolescents; Kinder- und Jugendkrankenhaus auf der Bult; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Kordonouri","sequence":"additional","affiliation":[{"name":"Diabetes Centre for Children and Adolescents; Kinder- und Jugendkrankenhaus auf der Bult; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Granhall","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology and Oral Delivery; Novo Nordisk A\/S; S\u00f8borg Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flemming","family":"S\u00f8ndergaard","sequence":"additional","affiliation":[{"name":"Biostatistics & Epidemiology; Novo Nordisk A\/S; Aalborg \u00d8st Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels Rode","family":"Kristensen","sequence":"additional","affiliation":[{"name":"Quantitative Clinical Pharmacology; Novo Nordisk A\/S; S\u00f8borg Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Haahr","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology; Novo Nordisk A\/S; S\u00f8borg Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Danne","sequence":"additional","affiliation":[{"name":"Diabetes Centre for Children and Adolescents; Kinder- und Jugendkrankenhaus auf der Bult; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2014,1,28]]},"reference":[{"key":"10.1111\/pedi.12116-BIB0001|pedi12116-cit-0001","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1399-5448.2008.00479.x","article-title":"State of the world's children with diabetes","volume":"10","author":"Daneman","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/pedi.12116-BIB0002|pedi12116-cit-0002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ecl.2012.08.001","article-title":"The epidemiology of type 1 diabetes in children","volume":"41","author":"Stanescu","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/pedi.12116-BIB0003|pedi12116-cit-0003","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cppeds.2012.07.002","article-title":"Type 1 diabetes: current concepts in epidemiology, pathophysiology, clinical care, and research","volume":"42","author":"Gan","year":"2012","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1111\/pedi.12116-BIB0004|pedi12116-cit-0004","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl 13","key":"10.1111\/pedi.12116-BIB0005|pedi12116-cit-0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-5448.2009.00612.x","article-title":"The DAWN Youth WebTalk Study: methods, findings, and implications","volume":"10","author":"Peyrot","year":"2009","journal-title":"Pediatr Diabetes"},{"issue":"3 Pt 1","key":"10.1111\/pedi.12116-BIB0006|pedi12116-cit-0006","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1542\/peds.113.3.e221","article-title":"Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy","volume":"113","author":"Burdick","year":"2004","journal-title":"Pediatrics"},{"key":"10.1111\/pedi.12116-BIB0007|pedi12116-cit-0007","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2223\/JPED.2003","article-title":"Physical activity in children with type 1 diabetes","volume":"86","author":"Miculis","year":"2010","journal-title":"J Pediatr (Rio J)"},{"key":"10.1111\/pedi.12116-BIB0008|pedi12116-cit-0008","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0145721708326699","article-title":"Are children with type 1 diabetes consuming a healthful diet? A review of the current evidence and strategies for dietary change","volume":"35","author":"Rovner","year":"2009","journal-title":"Diabetes Educ"},{"key":"10.1111\/pedi.12116-BIB0009|pedi12116-cit-0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2431-10-50","article-title":"Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review","volume":"10","author":"Barnard","year":"2010","journal-title":"BMC Pediatr"},{"issue":"suppl 1","key":"10.1111\/pedi.12116-BIB0010|pedi12116-cit-0010","first-page":"S426","article-title":"Multi-hexamer formation is the underlying basis for the ultra-long glucose-lowering effect of insulin degludec","volume":"54","author":"Kurtzhals","year":"2011","journal-title":"Diabetologia"},{"key":"10.1111\/pedi.12116-BIB0011|pedi12116-cit-0011","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s11095-012-0739-z","article-title":"Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin","volume":"29","author":"Jonassen","year":"2012","journal-title":"Pharm Res"},{"key":"10.1111\/pedi.12116-BIB0012|pedi12116-cit-0012","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1463-1326.2012.01627.x","article-title":"Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes","volume":"14","author":"Heise","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/pedi.12116-BIB0013|pedi12116-cit-0013","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1463-1326.2012.01638.x","article-title":"Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes","volume":"14","author":"Heise","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/pedi.12116-BIB0014|pedi12116-cit-0014","first-page":"188","article-title":"Insulin degludec: two-fold longer half-life and a more consistent pharmacokinetic profile than insulin glargine","volume":"28","author":"Heise","year":"2012","journal-title":"Endocr Abstr"},{"key":"10.1111\/pedi.12116-BIB0015|pedi12116-cit-0015","doi-asserted-by":"crossref","first-page":"858","DOI":"10.2337\/dc12-1668","article-title":"The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26-week, randomized, open-label, parallel-group, treat-to-target trial in people with type 2 diabetes","volume":"36","author":"Meneghini","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12116-BIB0016|pedi12116-cit-0016","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1210\/jc.2012-3249","article-title":"Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension","volume":"98","author":"Mathieu","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/pedi.12116-BIB0017|pedi12116-cit-0017","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(12)60204-9","article-title":"Insulin degludec, an ultra-long-acting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial","volume":"379","author":"Heller","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/pedi.12116-BIB0018|pedi12116-cit-0018","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/clinchem\/42.9.1518","article-title":"Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method","volume":"42","author":"Ullman","year":"1996","journal-title":"Clin Chem"},{"key":"10.1111\/pedi.12116-BIB0019|pedi12116-cit-0019","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/diacare.28.5.1245","article-title":"Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia","volume":"28","author":"Workgroup on Hypoglycemia, American Diabetes Association","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12116-BIB0020|pedi12116-cit-0020","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/sj.ejcn.1601473","article-title":"A chart to link child centiles of body mass index, weight and height","volume":"56","author":"Cole","year":"2002","journal-title":"Eur J Clin Nutr"},{"key":"10.1111\/pedi.12116-BIB0021|pedi12116-cit-0021","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.2337\/diacare.26.11.3087","article-title":"Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes","volume":"26","author":"Danne","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12116-BIB0022|pedi12116-cit-0022","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/j.1651-2227.2007.00494.x","article-title":"Paediatric diabetes: achieving practical, effective insulin therapy in type 1 and type 2 diabetes","volume":"96","author":"Danne","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1111\/pedi.12116-BIB0023|pedi12116-cit-0023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/000992289603500403","article-title":"Accuracy of injection site identification among children with insulin dependent diabetes mellitus: a comparison of traditional and new visual aids","volume":"35","author":"Monaco","year":"1996","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1111\/pedi.12116-BIB0024|pedi12116-cit-0024","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diacare.25.3.634","article-title":"Lipohypertrophy in young patients with type 1 diabetes","volume":"25","author":"Kordonouri","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1111\/pedi.12116-BIB0025|pedi12116-cit-0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1463-1326.2006.00685.x","article-title":"Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes","volume":"9","author":"Klein","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/pedi.12116-BIB0026|pedi12116-cit-0026","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1399-5448.2008.00443.x","article-title":"Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial","volume":"9","author":"Danne","year":"2008","journal-title":"Pediatr Diabetes"}],"container-title":["Pediatric Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpedi.12116","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/pedi.12116\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:06:37Z","timestamp":1671818797000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pedi.12116"}},"subtitle":["Insulin degludec in children\/adolescents"],"short-title":[],"issued":{"date-parts":[[2014,1,28]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1111\/pedi.12116","relation":{},"ISSN":["1399-543X"],"issn-type":[{"value":"1399-543X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,28]]}}}